IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 1 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,855 | -9.9% | 2,521,284 | +4.0% | 0.02% | -5.0% |
| Q2 2023 | $145,309 | +112.4% | 2,423,420 | +75.2% | 0.02% | +100.0% |
| Q1 2023 | $68,398 | -10.2% | 1,383,440 | +3.7% | 0.01% | -16.7% |
| Q4 2022 | $76,127 | -99.9% | 1,333,916 | +14.6% | 0.01% | +33.3% |
| Q3 2022 | $54,618,000 | +366.3% | 1,163,561 | +270.7% | 0.01% | +800.0% |
| Q2 2022 | $11,712,000 | +14.1% | 313,899 | -8.6% | 0.00% | 0.0% |
| Q1 2022 | $10,264,000 | -21.1% | 343,279 | -9.6% | 0.00% | 0.0% |
| Q4 2021 | $13,007,000 | -3.1% | 379,891 | +4.9% | 0.00% | 0.0% |
| Q3 2021 | $13,420,000 | -6.4% | 362,026 | -1.4% | 0.00% | 0.0% |
| Q2 2021 | $14,343,000 | -13.1% | 367,304 | -5.3% | 0.00% | -50.0% |
| Q1 2021 | $16,513,000 | – | 387,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $21,500,000 | 16.53% |
| Velan Capital Investment Management LP | 293,385 | $10,946,000 | 11.10% |
| Paradigm Biocapital Advisors LP | 667,417 | $24,901,000 | 4.96% |
| RTW INVESTMENTS, LP | 3,996,154 | $149,097,000 | 3.85% |
| Rock Springs Capital Management LP | 2,671,652 | $99,679,000 | 2.90% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $14,387,000 | 2.18% |
| Samsara BioCapital, LLC | 160,963 | $6,006,000 | 1.60% |
| Avidity Partners Management LP | 1,350,000 | $50,369,000 | 1.16% |
| Pier Capital, LLC | 123,394 | $4,604,000 | 0.78% |
| Omega Fund Management, LLC | 51,535 | $1,923,000 | 0.61% |